Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.

@article{Iso2013DiscrepancyOB,
  title={Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.},
  author={Yukihiro Iso and Tokihiko Sawada and Junji Kita and Takayuki Shiraki and Yuki Sakuraoka and Masato Kato and Mitsugi Shimoda and K. K. Kubota},
  journal={Hepato-gastroenterology},
  year={2013},
  volume={60 127},
  pages={1624-6}
}
ABO-incompatible living-donor liver transplantation (ABO-LDLT) is generally more difficult to perform than ABO-incompatible kidney transplantation. Despite introduction of rituximab, ABO-LDLT in non-responders is a still difficult issue. A 23-year-old woman with primary sclerosing cholangitis underwent LDLT. The recipient's blood type was 0(+) and the donor… CONTINUE READING